Pacemaker Implantation After Mitral Valve Surgery With Atrial Fibrillation Ablation.

Published

Journal Article

BACKGROUND: The incidence of permanent pacemaker (PPM) implantation is higher following mitral valve surgery (MVS) with ablation for atrial fibrillation (AF) compared with MVS alone. OBJECTIVES: This study identified risk factors and outcomes associated with PPM implantation in a randomized trial that evaluated ablation for AF in patients who underwent MVS. METHODS: A total of 243 patients with AF and without previous PPM placement were randomly assigned to MVS alone (n = 117) or MVS + ablation (n = 126). Patients in the ablation group were further randomized to pulmonary vein isolation (PVI) (n = 62) or the biatrial maze procedure (n = 64). Using competing risk models, this study examined the association among PPM and baseline and operative risk factors, and the effect of PPM on time to discharge, readmissions, and 1-year mortality. RESULTS: Thirty-five patients received a PPM within the first year (14.4%), 29 (83%) underwent implantation during the index hospitalization. The frequency of PPM implantation was 7.7% in patients randomized to MVS alone, 16.1% in MVS + PVI, and 25% in MVS + biatrial maze. The indications for PPM were similar among patients who underwent MVS with and without ablation. Ablation, multivalve surgery, and New York Heart Association functional (NYHA) functional class III/IV were independent risk factors for PPM implantation. Length of stay post-surgery was longer in patients who received PPMs, but it was not significant when adjusted for randomization assignment (MVS vs. ablation) and age (hazard ratio [HR]: 0.81; 95% confidence interval [CI]: 0.61 to 1.08; p = 0.14). PPM implantation did not increase 30-day readmission rate (HR: 1.43; 95% CI: 0.50 to 4.05; p = 0.50). The need for PPM was associated with a higher risk of 1-year mortality (HR: 3.21; 95% CI: 1.01 to 10.17; p = 0.05) after adjustment for randomization assignment, age, and NYHA functional class. CONCLUSIONS: AF ablation, multivalve surgery, and NYHA functional class III/IV were associated with an increased risk for permanent pacing. PPM implantation following MVS was associated with a significant increase in 1-year mortality. (Surgical Ablation Versus No Surgical Ablation for Patients With Atrial Fibrillation Undergoing Mitral Valve Surgery; NCT00903370).

Full Text

Duke Authors

Cited Authors

  • DeRose, JJ; Mancini, DM; Chang, HL; Argenziano, M; Dagenais, F; Ailawadi, G; Perrault, LP; Parides, MK; Taddei-Peters, WC; Mack, MJ; Glower, DD; Yerokun, BA; Atluri, P; Mullen, JC; Puskas, JD; O'Sullivan, K; Sledz, NM; Tremblay, H; Moquete, E; Ferket, BS; Moskowitz, AJ; Iribarne, A; Gelijns, AC; O'Gara, PT; Blackstone, EH; Gillinov, AM; CTSN Investigators,

Published Date

  • May 21, 2019

Published In

Volume / Issue

  • 73 / 19

Start / End Page

  • 2427 - 2435

PubMed ID

  • 31097163

Pubmed Central ID

  • 31097163

Electronic International Standard Serial Number (EISSN)

  • 1558-3597

Digital Object Identifier (DOI)

  • 10.1016/j.jacc.2019.02.062

Language

  • eng

Conference Location

  • United States